Suppr超能文献

一种与HLA - DR2肽交叉反应的麻风分枝杆菌特异性人类T细胞表位。

A Mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide.

作者信息

Anderson D C, van Schooten W C, Barry M E, Janson A A, Buchanan T M, de Vries R R

机构信息

University of Washington, Seattle 98195.

出版信息

Science. 1988 Oct 14;242(4876):259-61. doi: 10.1126/science.2459778.

Abstract

Mycobacterium leprae induces T cell reactivity and protective immunity in the majority of exposed individuals, but the minority that develop leprosy exhibit various types of immunopathology. Thus, the definition of epitopes on M. leprae antigens that are recognized by T cells from different individuals might result in the development of an effective vaccine against leprosy. A sequence from the 65-kD protein of this organism was recognized by two HLA-DR2-restricted, M. leprae-specific helper T cell clones that were derived from a tuberculoid leprosy patient. Synthetic peptides were used to define this epitope as Leu-Gln-Ala-Ala-Pro-Ala-Leu-Asp-Lys-Leu. A similar peptide that was derived from the third hypervariable region of the HLA-DR2 chain, Glu-Gln-Ala-Arg-Ala-Ala-Val-Asp-Thr-Tyr, also activated the same clones. The unexpected cross-reactivity of this M. leprae-specific DR2-restricted T cell epitope with a DR2 peptide may have to be considered in the design of subunit vaccines against leprosy.

摘要

麻风分枝杆菌在大多数接触者中可诱导T细胞反应性和保护性免疫,但少数发展为麻风病的个体表现出各种类型的免疫病理反应。因此,确定麻风分枝杆菌抗原上被不同个体的T细胞识别的表位,可能会促成一种有效的麻风病疫苗的研发。来自该菌65-kD蛋白的一个序列被两个HLA-DR2限制性、麻风分枝杆菌特异性辅助性T细胞克隆识别,这两个克隆源自一名结核样型麻风病患者。合成肽被用于将该表位确定为Leu-Gln-Ala-Ala-Pro-Ala-Leu-Asp-Lys-Leu。一个源自HLA-DR2链第三个高变区的类似肽Glu-Gln-Ala-Arg-Ala-Ala-Val-Asp-Thr-Tyr,也激活了相同的克隆。在设计抗麻风病亚单位疫苗时,可能必须考虑这种麻风分枝杆菌特异性DR2限制性T细胞表位与DR2肽的意外交叉反应性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验